At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutionsSAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc.

UD developmental biologist studies genetics of jaw joint disorder with NIH funding ...

Scinai Immunotherapeutics Ltd. ;("Scinai", or the "Company"), today announced that, following an additional review by the Israel Innovation Authority (IIA), its project to advance a robotic aseptic ...